Financial instrument specification
AstraZeneca PLC (LSE) AZN
Contract Size, MT4/MT5 100 /100
Minimum spread 0.02
Swap long, MT4/MT5, (%) -6.7/-0.4
Swap short, MT4/MT5, (%) -6.7/-0.4
Precision (digits) 2
Spread
Average spread 0.03497
Bid
Ask
Commission, % 0.1
Execution type: Market execution
Hedged Margin 50,00%
Margin, MT4/MT5 25%/ 25%
Swap history
Triple swap day, MT4/MT5 Friday/Friday
Server Time GMT+2

Trading schedule (CET)

Mon: 10:02-18:29

Tue: 10:02-18:29

Wed: 10:02-18:29

Thu: 10:02-18:29

Fri: 10:02-18:29

Calculator Loading

About the asset

Name AstraZeneca PLC (LSE)
Ticker AZN
Branch AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Products Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153.
Year of foundation 1992
Headquarters Cambridge, the United Kingdom
ISIN code GB0009895292

How to buy or sell AstraZeneca PLC (LSE)

  • Register on the website and set up a personal account.
  • We recommends to top up the account for a minimum of $100 to trade.
  • Invest into the instrument that interests you.

If your trading positions are open from Wednesday to Thursday, the swap on them will be tripled. The exception is CFDs on commodities and CFDs on indexes: a triple swap on these instruments is charged on Friday. Information about swaps for your transactions is updated in the trading terminal daily at 23:55.

Short selling on some types of financial instruments may be temporarily prohibited. This is due to restrictions on the part of counterparties or regulatory authorities. Please check the information in the Support Service.